2 terminated, 1 completed. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Indium-105: new trials by email Literature Review of Indium-105 trials Research Report on Indium-105
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil Tregopil - Type 1 Diabetes Mellitus (T1DM) | Phase 1 | Terminated | Biocon Limited | 55 | 2019-10-28 | 2022-06-27 |
| Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients Insulin Tregopil, Insulin Aspart - Type2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Biocon Limited | 143 | 2017-12-26 | 2020-05-15 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients IN-105, Insulin Lispro Injection - Type 1 Diabetes Mellitus | Phase 1 | Terminated | Biocon Limited | 20 | 2010-08-21 | 2018-01-23 |
Biocon Limited (3)
India (2) · Germany (1)
Dr Bipin Kumar Sethi, MD, DM (1) · Dr. Aravind R Sosale, DNB (1) · Dr. K.M. Prasanna Kumar, MD, DM (1) · Dr. Neeta Deshpande, MD (1) · Dr. Sanjay Kalra, MD, DM (1) · Subramanian Loganathan, MD (1)